TransCode Therapeutics, Inc. (NASDAQ: RNAZ) (the “Company”), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, announced today that it withdrew the Registration Statement on Form S-1 it filed with the U.S. Securities and Exchange Commission on November 28, 2022, and amended on November 30, 2022. The withdrawal reflects the Company’s belief that current market conditions are not conducive for an offering on terms that would be in the best interests of the Company's stockholders.
Wednesday, December 7, 2022
HHS ‘knowingly’ transferred migrant children to criminals, sex traffickers
Republican senators are accusing the Department of Health and Human Services of "knowingly" transferring unaccompanied migrant children to criminals, based on a new whistleblower claim.
In letters to HHS Secretary Xavier Becerra and Senate Homeland Security and Governmental Affairs (HSGAC) Chairman Gary Peters, D-Mich., first obtained by Fox News Digital, Sen. Ron Johnson, R-Wis., and other GOP senators demand a hearing to investigate the shocking whistleblower claim.
"We write in response to recently reported claims by federal employee whistleblower that the Department of Health and Human Services (HHS) is knowingly transferring unaccompanied migrant children in the custody of criminals, including sex traffickers," the senators wrote.
"This cannot be swept under the rug. Congress must immediately take action to stop the atrocities this whistleblower claims are being committed by the federal government itself," they wrote. "The Senate Committee on Homeland Security and Governmental Affairs must call a hearing to further investigate these whistleblower claims."
The senators cited recently released video of a former HHS employee, Tara Lee Rodas, who was detailed to the Emergency Intake Site in Pomona, California. Senators said her testimony described several "disturbing" claims about the agency's Unaccompanied Children Program, including the department's failure to place children into the homes of "safe, non-criminal sponsors."
"[Most people] have no idea that children are going to unrelated people. That children are definitely — we have proof, evidence — that they are being recruited and transported. They are then in debt bondage," Rodas alleged in the video published by Project Veritas.
"We know that children have been trafficked through the [Unaccompanied Children] program," she said, adding that the government is "paying to put children in the hands of criminals."
House Minority Leader led a GOP delegation meeting with Border Patrol in Eagle Pass, Texas. (Fox News' Bill Melugin)
HHS acknowledges that unaccompanied children are "especially vulnerable" to trafficking and abuse, while noting the "majority" of the children are cared for by a network of licensed providers.
"The age of these individuals, their separation from parents and relatives, and the hazardous journey they take make UC especially vulnerable to human trafficking, exploitation, and abuse," HHS states on its webpage detailing the program.
"The majority of UC are cared for through a network of state licensed ORR-funded care providers, most of which are located close to areas where immigration officials apprehend large numbers of children. These provider facilities are state licensed and must meet ORR requirements to ensure a high level of quality of care. Care providers operate under cooperative agreements and contract," HHS says.
HHS and Sen. Peters did not immediately respond to Fox News Digital's requests for comment.
Sen. Joni Ernst, R-Iowa, said she is worried about the trafficking of women and girls across the border. (Office of Sen. Joni Ernst)
The accusations by the senators come after border agents have said they are worried about the alarming number of young girls who are being "brutally" raped and assaulted by human smugglers as they trek across the southern border, and have demanded the Biden administration to take immediate action to stop these "heartbreaking" crimes.
"The Border Patrol, they told us that about 30% of the women and girls that are being trafficked by the cartels up to the border are being sexually abused along the way. And those are just the ones that are reporting," Sen. Joni Ernst, R-Iowa, told Fox News Digital in July during a border trip.
"And so the Border Patrol agents feel that 60% of them having been abused would be a more accurate number. So it really is appalling," she said.
NEXGEL Announces Share Repurchase Program
NEXGEL, Inc. ("NEXGEL" or the "Company") (NASDAQ: NXGL, NXGLW), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, announced today that its Board of Directors has approved a share repurchase program, effective immediately, with authorization to purchase up to $500,000 of the Company's common shares.
Under the program, any repurchases will be made in the open market in accordance with all applicable securities laws and regulations, including Rule 10b-18 of the Securities Exchange Act of 1934, as amended. The repurchase program does not obligate the Company to acquire any particular amount of common shares, and the repurchase program may be suspended or discontinued at any time by our Board of Directors.
https://finance.yahoo.com/news/nexgel-announces-share-repurchase-program-123000676.html
First AML Patient Successfully Transplanted with Vor Bio Investigational Trem-cel, Tolerated Mylotarg
Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced initial clinical data from VBP101, its Phase 1/2a multicenter, open-label, first-in-human study of tremtelectogene empogeditemcel or “trem-cel” (formerly VOR33) in patients with acute myeloid leukemia (AML). The data observed from the first treated patient support the potential of a trem-cel transplant to be successfully manufactured, to engraft normally, and to maintain blood counts following treatment with the CD33-targeted therapy Mylotarg. The clinical trial continues to enroll patients and additional data are expected in 2023.
Conference Call & Webcast Information
Members of the Vor Bio management team, joined by Dr. Brenda Cooper, will conduct a live conference call and webcast today at 8:00 am Eastern Time.
Listeners can register for the webcast via this link.
Analysts wishing to participate in the Q&A session should use this link.
A replay of the webcast will be available via the investor section of the Company’s website at www.vorbio.com approximately two hours after the call’s conclusion.
https://finance.yahoo.com/news/first-aml-patient-successfully-transplanted-123000776.html
Prometheus: Promising Results In Irritable Bowel Disease
Prometheus Biosciences (RXDX) reported promising results from two inflammatory disease studies on Wednesday, and RXDX stock catapulted by a triple-digit percentage.
The company studied its drug in patients with ulcerative colitis and Crohn's disease, two forms of irritable bowel disease. More than a quarter of ulcerative colitis patients and almost half of the Crohn's disease group entered remission 12 weeks after treatment.
Now, Prometheus is planning to run final-phase studies in 2023.
In premarket action on the stock market today, RXDX stock skyrocketed 176.2% near 99.60. That put shares on deck to open at a record high.
Axsome: New Major Depressive Disorder Trial Data
Improvement in cognitive and physical functioning, measured by the CPFQ patient-rated scale, starting at week 1 and sustained over 12 months
Improvement in disability, measured by the SDS, starting at week 1 and sustained over 12 months
Replimune: Agreement with Roche to Develop RP3 In Colorectal Cancer and Hepatocellular Carcinoma
RP3 will be developed in combination with atezolizumab and bevacizumab for the third-line treatment of colorectal cancer (CRC) and for the first- and second-line treatment of hepatocellular carcinoma (HCC)
Includes cost sharing for development in third-line CRC and second-line HCC
https://finance.yahoo.com/news/replimune-enters-clinical-collaboration-agreement-113000034.html
Subscribe to:
Posts (Atom)